Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Zander

Showing results (71-80 of 206) with videos related to

Pageof 21
Sort By:
Journal of Neurology|August 27, 2002
Intensified PCV-chemotherapy with optional stem cell support in recurrent malignant oligodendrogliomaThomas Zander, Willy Nettekoven, Jürgen A Kraus, et al.
Molecular and Clinical Oncology|May 23, 2017
Copy-number variation and protein expression of DOT1L in pancreatic adenocarcinoma as a potential drug targetHeike Loeser, Dirk Waldschmidt, Fabian Kuetting, et al.
Lung Cancer (Amsterdam, Netherlands)|June 26, 2012
Monitoring reversible and irreversible EGFR inhibition with erlotinib and afatinib in a patient with EGFR-mutated non-small cell lung cancer (NSCLC) using sequential [18F]fluorothymidine (FLT-)PETMatthias Scheffler, Carsten Kobe, Thomas Zander, et al.
International Journal of Cancer|March 5, 2026
Adherens junction protein expression is associated with poor response to neoadjuvant FLOT chemotherapy and pro-inflammatory tumor microenvironment in esophageal adenocarcinomaBastian Grothey, Heike Löser, Tillmann Bedau, et al.
The AAPS Journal|August 20, 2015
A Modeling and Simulation Framework for Adverse Events in Erlotinib-Treated Non-Small-Cell Lung Cancer PatientsAhmed Abbas Suleiman, Sebastian Frechen, Matthias Scheffler, et al.
Virchows Archiv : an International Journal of Pathology|February 13, 2025
AI-based tumor-stroma ratio quantification algorithm: comprehensive evaluation of prognostic role in primary colorectal cancerRita Carvalho, Thomas Zander, Vincenzo Mitchell Barroso, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 17, 2014
Modeling tumor dynamics and overall survival in advanced non-small-cell lung cancer treated with erlotinibAhmed Abbas Suleiman, Sebastian Frechen, Matthias Scheffler, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 13, 2025
Artificial Intelligence-Based Single-Cell Analysis as a Next-Generation Histologic Grading Approach in Colorectal Cancer: Prognostic Role and Tumor Biology AssessmentVincenzo Mitchell Barroso, Zhilong Weng, Lennert Glamann, et al.
Frontiers in Oncology|December 4, 2023
Combined score of Y chromosome loss and T-cell infiltration improves UICC based stratification of esophageal adenocarcinomaVerena Maria Raters, Florian Gebauer, Heike Löser, et al.
Oncology Research and Treatment|September 21, 2020
Economic Impact of the Introduction of Outpatient Medical Specialist Care (ASV) of Gastrointestinal Cancer Patients from a German Hospital Management PerspectiveFlorian Jakobs, Ruben M W A Drost, Anna Kron, et al.
Pageof 21

Showing results (71-80 of 206) with videos related to

Sort By:
Pageof 21
Journal of Neurology|August 27, 2002
Intensified PCV-chemotherapy with optional stem cell support in recurrent malignant oligodendrogliomaThomas Zander, Willy Nettekoven, Jürgen A Kraus, et al.
Molecular and Clinical Oncology|May 23, 2017
Copy-number variation and protein expression of DOT1L in pancreatic adenocarcinoma as a potential drug targetHeike Loeser, Dirk Waldschmidt, Fabian Kuetting, et al.
Lung Cancer (Amsterdam, Netherlands)|June 26, 2012
Monitoring reversible and irreversible EGFR inhibition with erlotinib and afatinib in a patient with EGFR-mutated non-small cell lung cancer (NSCLC) using sequential [18F]fluorothymidine (FLT-)PETMatthias Scheffler, Carsten Kobe, Thomas Zander, et al.
International Journal of Cancer|March 5, 2026
Adherens junction protein expression is associated with poor response to neoadjuvant FLOT chemotherapy and pro-inflammatory tumor microenvironment in esophageal adenocarcinomaBastian Grothey, Heike Löser, Tillmann Bedau, et al.
The AAPS Journal|August 20, 2015
A Modeling and Simulation Framework for Adverse Events in Erlotinib-Treated Non-Small-Cell Lung Cancer PatientsAhmed Abbas Suleiman, Sebastian Frechen, Matthias Scheffler, et al.
Virchows Archiv : an International Journal of Pathology|February 13, 2025
AI-based tumor-stroma ratio quantification algorithm: comprehensive evaluation of prognostic role in primary colorectal cancerRita Carvalho, Thomas Zander, Vincenzo Mitchell Barroso, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 17, 2014
Modeling tumor dynamics and overall survival in advanced non-small-cell lung cancer treated with erlotinibAhmed Abbas Suleiman, Sebastian Frechen, Matthias Scheffler, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 13, 2025
Artificial Intelligence-Based Single-Cell Analysis as a Next-Generation Histologic Grading Approach in Colorectal Cancer: Prognostic Role and Tumor Biology AssessmentVincenzo Mitchell Barroso, Zhilong Weng, Lennert Glamann, et al.
Frontiers in Oncology|December 4, 2023
Combined score of Y chromosome loss and T-cell infiltration improves UICC based stratification of esophageal adenocarcinomaVerena Maria Raters, Florian Gebauer, Heike Löser, et al.
Oncology Research and Treatment|September 21, 2020
Economic Impact of the Introduction of Outpatient Medical Specialist Care (ASV) of Gastrointestinal Cancer Patients from a German Hospital Management PerspectiveFlorian Jakobs, Ruben M W A Drost, Anna Kron, et al.
Pageof 21